MAIA Biotechnology Balance Sheet Health
Financial Health criteria checks 6/6
MAIA Biotechnology has a total shareholder equity of $477.5K and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $7.6M and $7.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$7.15m |
Equity | US$477.51k |
Total liabilities | US$7.09m |
Total assets | US$7.57m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MAIA's short term assets ($7.6M) exceed its short term liabilities ($4.9M).
Long Term Liabilities: MAIA's short term assets ($7.6M) exceed its long term liabilities ($2.2M).
Debt to Equity History and Analysis
Debt Level: MAIA is debt free.
Reducing Debt: MAIA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MAIA has sufficient cash runway for 7 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: MAIA is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.